Malaria News and Research

Latest Malaria News and Research

Global Fund Board approves 45 new two-year grants as part of Transitional Funding Mechanism

"The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has approved 45 new two-year grants, from 37 countries, totaling $419.2 million, to fund essential prevention, treatment, and care services provided to the people affected by the three diseases," according to a Global Fund press release.

30 Aug 2012

Sri Lanka succeeds in reducing malaria cases by 99.9% since 1999

Despite nearly three decades of conflict, Sri Lanka has succeeded in reducing malaria cases by 99.9 percent since 1999 and is on track to eliminate the disease entirely by 2014.

30 Aug 2012

Global Fund, Nigeria sign agreements worth $225M to prevent, treat malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria and Nigeria on Friday "signed two grant agreements ... worth a total of $225 million to support programs that will prevent and treat malaria," a Global Fund press release reports.

29 Aug 2012

MMV390048 shows potent activity against multiple points in malaria parasite's lifecycle

A recently discovered compound from the aminopyridine class not only has the potential to become part of a single-dose cure for all strains of malaria, but might also be able to block transmission of the parasite from person to person, according to a research collaboration involving the Medicines for Malaria Venture (MMV), based in Switzerland, and the Drug Discovery and Development Centre (H3-D) at the University of Cape Town, South Africa.

29 Aug 2012

South Sudan refugee health situation 'alarming,' U.N. warns

"The situation of 170,000 Sudanese refugees living in camps and settlements across South Sudan's Unity and Upper Nile states is alarming and there are worries about an outbreak of cholera, U.N. refugee agency officials said on Friday," the Associated Press/Washington Post reports.

28 Aug 2012

Process for setting new global development goals should be open, inclusive

In this CNN opinion piece, Jamie Drummond, co-founder and executive director of ONE, notes the 2015 deadline for the Millennium Development Goals (MDGs) is approaching, assesses progress towards these goals and examines issues surrounding the creation of a new set of goals.

28 Aug 2012

PEI adjuvant improves effect of vaccines against flu, HIV and herpes

Oxford University scientists have discovered a compound that greatly boosts the effect of vaccines against viruses like flu, HIV and herpes in mice.

26 Aug 2012

Global Fund releases funding recommendations for Transitional Funding Mechanism

"The Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday released the funding recommendations of its Technical Review Panel for the Transitional Funding Mechanism," the Stop TB Partnership reports in an article on its webpage.

26 Aug 2012

New MMV framework to evaluate risk of resistance for antimalarials

Medicines for Malaria Venture has developed a framework to evaluate the risk of resistance for the antimalarial compounds in its portfolio. A paper based on this work: A framework for assessing the risk of resistance for antimalarials in development has been published in the Malaria Journal today.

23 Aug 2012

Child mortality at double emergency rate in South Sudan refugee camp, MSF reports

"Children in a refugee camp in South Sudan are dying at more than twice the rate internationally recognized as an emergency, according to new figures released by Medecins Sans Frontieres (MSF)," the Guardian reports.

22 Aug 2012

Massachusetts Institute of Technology to honor IHME's health measurement expert

For the first time, a prestigious technical innovation honor from the Massachusetts Institute of Technology (MIT) will go to an expert in health measurement: Abraham Flaxman, an Assistant Professor of Global Health at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington (UW).

22 Aug 2012

Genetic key to severe malaria resistance uncovered

Researchers have identified two genetic variants linked with human resistance to severe malaria.

21 Aug 2012

Women in developing countries could play a major role in remedying sanitation and water crisis

People in ancient Rome 2,000 years ago had better access to clean water and sanitation that keeps disease-causing human excrement out of contact with people than many residents of the 21st century, a scientist said here today.

21 Aug 2012

World Mosquito Day marks 114 years of battle against malaria

"Each year on August 20, the London School of Hygiene and Tropical Medicine (LSHTM) celebrates World Mosquito Day to honor the date in 1897 when British doctor Ronald Ross discovered that female mosquitoes transmit malaria between human beings," AlertNet reports.

21 Aug 2012

Paper-strip test could identify counterfeit versions of faked medicines in the world

In a thrust against the major problem of counterfeit medicines sold in developing countries, which causes thousands of illnesses and deaths annually, scientists today described development of a simple, paper-strip test that people could use to identify counterfeit versions of one of the most-frequently faked medicines in the world.

20 Aug 2012

New birth-control strategy for mosquitoes can combat malaria

Using information about the unique mating practices of the male malaria mosquito ― which, unlike any other insect, inserts a plug to seal its sperm inside the female ― scientists are zeroing in on a birth-control drug for Anopheles mosquitoes, deadly carriers of the disease that threatens 3 billion people, has infected more than 215 million and kills 655,000 annually.

20 Aug 2012

New book on malaria tells story of Plasmodium falciparum Genome Project

Few infectious diseases can rival malaria's ability to kill and cripple. Each year the disease causes hundreds of millions of people to be sickened and more than a million - mostly African children under the age of five - die.

18 Aug 2012

Franchise clinics improve healthcare access for children in developing world

Franchise health clinics could substantially increase access to essential vaccinations and treatments among children living in low-income countries, regardless of their household income status, report researchers.

17 Aug 2012

Blog examines use of controversial HIV drug in Malawi

This post in the Center for Global Health Policy's "Science Speaks" blog examines the use of stavudine, "also known as d4T, an antiretroviral treatment that was dropped in wealthy countries years ago and that the World Health Organization has recommended stop being included in treatment programs," to treat HIV in Malawi.

17 Aug 2012

Nostrum, VCU sign license agreement to develop inhaled dapsone for respiratory diseases

Virginia Commonwealth University and Nostrum Pharmaceuticals, LLC, are pleased to announce the signing of a license agreement for the development of inhaled dapsone for the treatment of respiratory diseases.

17 Aug 2012